FibroGen(FGEN) - 2023 Q3 - Earnings Call Transcript

Thane Wettig - Chief Executive Officer Mark Eisner - Chief Medical Officer Operator Joining me on today's call are Thane Wettig, our Chief Executive Officer; Juan Graham, our Chief Financial Officer; Dr. Mark Eisner, our Chief Scientific Officer and Chris Chung, our Senior Vice President of China Operations. Following our prepared remarks, we will open the call to your questions. With that, I would like to turn the call over to Thane Wettig. Thanks Dave, and good afternoon, everyone. Welcome to our third qu ...